Tenofovir DF 300 mg + Lamivudine 300 mg
This fixed-dose combination of two nucleos(t)ide reverse transcriptase inhibitors serves as a foundational component in antiretroviral therapy, contributing to sustained viral suppression in patients with HIV-1 infection when used alongside other recommended agents.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Tenofovir DF 300 mg + Lamivudine 300 mg
This fixed-dose combination of two nucleos(t)ide reverse transcriptase inhibitors serves as a foundational component in antiretroviral therapy, contributing to sustained viral suppression in patients with HIV-1 infection when used alongside other recommended agents.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Tenofovir DF 300 mg + Lamivudine 300 mg
This fixed-dose combination of two nucleos(t)ide reverse transcriptase inhibitors serves as a foundational component in antiretroviral therapy, contributing to sustained viral suppression in patients with HIV-1 infection when used alongside other recommended agents.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets